CurAegis Technologies Inc (fka CRGS)

[Oakie1]

Torvecian, you said, "I believe we are seeing the first real monetizing




progress unfold right now...."

Now given Jim Donnelly told us on June 13, 2018 to expect hundreds of thousands of CURA B2B users, I'd say the two divisions are in a monetizing race -- neck to neck -- at least according to what company officials have told us. Who comes in first, I wouldn't care. But I want to hear more about CURA from Kaplan after Donnelly's very vivid annual meeting testimony, while we're in a quiet period during pump negotiations.


Again, if the share price stays bounded by 33 cents given what we now have in front of us (re both CURA and the AEGIS pump), well, that would be quite, quite, quite suspicious. Further explanation would be needed beyond what we officially know to understand it.

Life is your film. -- NEIL YOUNG